cmi_logo.png
[Latest] Global Roasted Coffee Market Size/Share Worth USD 73.46 Billion by 2032 at a 5.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
February 19, 2024 12:30 ET | Custom Market Insights
Austin, TX, USA, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Roasted Coffee Market Size, Trends and Insights By Type (Arabica, Robusta), By...
Logo.png
GRI Bio Announces Reverse Stock Split
January 26, 2024 08:05 ET | GRI Bio, Inc.
GRI’s common stock is expected to begin trading on a post-split adjusted basis on January 30, 2024 LA JOLLA, CA, Jan. 26, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the...
NOVARTIS logo.jpg
Novartis expands production of Pluvicto™ with addition of its largest and most advanced radioligand therapy manufacturing facility in Indianapolis
January 05, 2024 09:23 ET | Novartis Pharma AG
FDA approval of the company’s second US Radioligand Therapy (RLT) manufacturing facility increases RLT production capacity to 250,000 doses in 2024 and beyondNew 70,000-square foot RLT facility is the...
NOVARTIS logo.jpg
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
December 10, 2023 19:30 ET | Novartis Pharma AG
APPLY-PNH extension data show that continuous Fabhalta® (iptacopan) treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH) enabled sustained hemoglobin-level increases to...
NOVARTIS logo.jpg
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
December 08, 2023 09:15 ET | Novartis Pharma AG
With 5.6 months of additional follow-up and 78.3% of patients having completed Kisqali® (ribociclib) investigational treatment, the updated analysis shows sustained iDFS benefit and stability in...
logo.png
Autonomix Medical, Inc. Announces Appointment of Christopher C. Capelli, M.D. to Board of Directors
November 16, 2023 10:00 ET | Autonomix Medical, Inc.
THE WOODLANDS, TX, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device company focused on advancing innovative technologies to revolutionize how...
cmi_logo.png
[Latest] Global Disabled and Elderly Assistive Technology Market Size/Share Worth USD 66.84 Billion by 2030 at a 6.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate)
August 03, 2023 15:30 ET | Custom Market Insights
Austin, TX, USA, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Disabled and Elderly Assistive Technology Market Size, Trends and Insights By...
GMILogo_Vertical-Gradient.png
Rapid Diagnostics Market to cross USD 79 billion by 2032, says Global Market Insights Inc.
June 27, 2023 04:00 ET | Global Market Insights Inc.
Selbyville, Delaware, June 27, 2023 (GLOBE NEWSWIRE) -- Rapid Diagnostics Market size is set to surpass USD 79 billion by 2032, given the rising awareness regarding early disease diagnosis among...
researchdrivelogo.jpg
Global Digital Health Market Expected to Garner $1,045.8 Billion in Revenue and Grow at a CAGR of 33.4% during the Estimated Timeframe 2020-2027 | Research Dive
October 10, 2022 09:02 ET | Research Dive
New York, USA, Oct. 10, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global digital health market is anticipated to generate a revenue of $1,045.8 billion by...
Straits Research Pvt Ltd
OTC Artificial Tears Market Size is projected to reach USD 6.79 Billion by 2030, growing at a CAGR of 5.10%: Straits Research
August 18, 2022 10:30 ET | Straits Research
New York, United States, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The application of artificial tears protects and hydrates mucous membranes and alleviates dryness and irritation of the eyes. Artificial...